Can Phosphodiesterase 4 Inhibitor Therapy Be Used in Respiratory Diseases Other Than Chronic Obstructive Pulmonary Disease?

Selective phosphodiesterase 4 (PDE4) inhibitors have been extensively studied for the treatment of various respiratory diseases due to their broad anti-inflammatory and/or bronchodilator effects. Roflumilast, an oral selective PDE4 inhibitor, is currently used as a second-line treatment in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Goonathilake, Mastiyage R, Waqar, Sara, George, Sheeba, Jean-Baptiste, Wilford, Yusuf Ali, Amina, Inyang, Bithaiah, Koshy, Feeba Sam, George, Kitty, Poudel, Prakar, Chalasani, Roopa, Mohammed, Lubna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392891/
https://www.ncbi.nlm.nih.gov/pubmed/36017299
http://dx.doi.org/10.7759/cureus.27132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392891/
https://www.ncbi.nlm.nih.gov/pubmed/36017299
http://dx.doi.org/10.7759/cureus.27132

Ejemplares similares